Bluebird Bio looks like a pretty sweet swing long setup as the stock is testing uptrend channel support as large players volume surges higher. Bluebird Bio reported its quarterly earnings results on May 7, 2018. The company reported EPS of ($2.31) which missed the consensus estimate of ($2.01). Revenue crushed estimates, coming in at $15.96 Read More »
Gilead Sciences stock looks like a great setup on rumors circulating that Gilead has an experimental therapy that has completely eliminated breast cancer in women. I am unable to find the source of the rumors or verify its authenticity so caution is warranted. UPDATE: The source of the rumor is Bloomberg. Gilead Sciences’ experimental therapy Read More »
SUBSCRIBE OR SIGN IN
SUBSCRIBE OR SIGN IN
Exelixis stock has a good consolidation setup going into its earnings release on February 26, 2018.
Gilead Sciences looks like a good oversold, candle over candle setup.
SUBSCRIBE OR SIGN IN
The chart of Ionis Pharmaceuticals doesn’t look like much but the fundamentals show eye-popping revenue growth.
Synergy Pharmaceuticals has a PDUFA ruling coming within the next couple of days. The Twiggs Money Flow has started to run ahead of the FDA announcement.
Amgen stock looks like a good setup as the Twiggs Money Flow breaks into positive territory.
